Antibiotic market to reach US$ 74.07 billion by 2033; FDA approves GSK’s Blujepa for uncomplicated UTIs

Data Compilation
#PharmaFlow

Pipeline Prospector November 2025: Kimberly-Clark to buy Kenvue for US$ 48.7 bn; FDA approves Novartis’ gene therapy

Stock Recap
#PipelineProspector

Accupron

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

15 API Suppliers, 11 USDMF, 4 CEP/COS, 3 EU WC, 5 NDC API, 7 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

2 Drugs in Development

2 Drugs in Development

INTERMEDIATES

5 Intermediate Suppliers

5 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

233 FDF Dossiers, 77 FDA Orange Book, 123 Europe, 4 Canada, 3 Australia, 26 South Africa

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - EQ 10MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - EQ 20MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - EQ 40MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - EQ 5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

1 Rochem International Inc, 9 SPI Pharma, 13 DKSH, 1 Pharm-RX Chemical, 10 Boai NKY Pharmaceuticals Ltd, 3 Gangwal Healthcare, 3 Nanjing Well Pharmaceutical, 4 ACG Worldwide, 4 Actylis, 1 Aeon Procare, 2 Alcedo Pharmachem, 6 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 2 Ashland, 31 BASF, 1 CD Formulation, 1 Clariant, 10 Corel Pharma Chem, 4 DFE Pharma, 1 Esteem Industries, 1 Finar, 9 Gangwal Chemicals, 1 Huzhou Sunflower Pharmaceutical, 5 Ideal Cures, 2 Ingredion Pharma Solutions, 22 Kerry, 1 Keval Exports, 3 Kima Chemical, 6 Lonza Capsugel, 13 Microlex e.U, 2 Nitika Pharmaceutical Specialities, 2 Nomisma Healthcare, 5 Novo Excipients, 3 Pharmatrans-Sanaq, 5 Pluviaendo, 2 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 15 Roquette, 7 Seppic, 5 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 9 Sigachi Industries, 2 Silverline Chemicals, 2 The Dow Chemical Company, 2 Ulanqab Kema New Material, 3 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

65 Fillers, Diluents & Binders, 49 Coating Systems & Additives, 31 Granulation, 31 Direct Compression, 29 Thickeners and Stabilizers, 28 Controlled & Modified Release, 22 Disintegrants & Superdisintegrants, 17 Solubilizers, 16 Lubricants & Glidants, 14 Co-Processed Excipients, 13 Topical, 12 Chewable & Orodispersible Aids, 12 Film Formers & Plasticizers, 10 Taste Masking, 9 Empty Capsules, 9 Rheology Modifiers, 7 API Stability Enhancers, 6 Parenteral, 5 Coloring Agents, 5 Emulsifying Agents, 4 Vegetarian Capsules, 2 Surfactant & Foaming Agents

DIGITAL CONTENT

16 News #PharmaBuzz

16 News #PharmaBuzz

GLOBAL SALES INFORMATION

8 US Medicaid Prescriptions, 35 Regulatory FDF Prices

MARKET PLACE

7 APIs, 1 FDF Dossiers

PATENTS & EXCLUSIVITIES

8 Health Canada Patents

8 Health Canada Patents

REF. STANDARDS & IMPURITIES

3 EDQM, 2 Others

$ Xls download

Filters

Last Updated on PharmaCompass	Virtual Booth	Country	Certificate Holder	Certificate No.	Substance	Issue Date	Status	Type	End Date	Substance No.
29/11/2025	Aarti Pharmalabs	India	AARTI PHARMALABS LIMITED Mulund (W), Mumbai IN	R1-CEP 2016-100 - Rev 00	Quinapril hydrochloride	2023-02-01	Valid	Chemical		1763
29/11/2025	Aurobindo Pharma Limited	India	APITORIA PHARMA PRIVATE LIMITED Hyderabad IN	CEP 2013-160 - Rev 02	Quinapril hydrochloride	2023-11-16	Valid	Chemical		1763

Accupron

Accupron

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

15 API Suppliers

11 USDMF

4 CEP/COS

3 EU WC

5 NDC API

7 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

2 Drugs in Development

INTERMEDIATES

5 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

233 FDF Dossiers

77 FDA Orange Book

123 Europe

4 Canada

3 Australia

26 South Africa

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - EQ 10MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - EQ 20MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - EQ 40MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - EQ 5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

1 Rochem International Inc

9 SPI Pharma

13 DKSH

1 Pharm-RX Chemical

10 Boai NKY Pharmaceuticals Ltd

3 Gangwal Healthcare

3 Nanjing Well Pharmaceutical

4 ACG Worldwide

4 Actylis

1 Aeon Procare

2 Alcedo Pharmachem

6 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

2 Ashland

31 BASF

1 CD Formulation

1 Clariant

10 Corel Pharma Chem

4 DFE Pharma

1 Esteem Industries

1 Finar

9 Gangwal Chemicals

1 Huzhou Sunflower Pharmaceutical

5 Ideal Cures

2 Ingredion Pharma Solutions

22 Kerry

1 Keval Exports

3 Kima Chemical

6 Lonza Capsugel

13 Microlex e.U

2 Nitika Pharmaceutical Specialities

2 Nomisma Healthcare

5 Novo Excipients

3 Pharmatrans-Sanaq

5 Pluviaendo

2 Prachin Chemical

1 Qianhao Chemical (Hebei) Co., Ltd

2 Qualicaps

15 Roquette

7 Seppic

5 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

1 Shanghai Welltone Material Technology Co., Ltd

9 Sigachi Industries

2 Silverline Chemicals

2 The Dow Chemical Company

2 Ulanqab Kema New Material

3 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

65 Fillers, Diluents & Binders

49 Coating Systems & Additives

TABLET;ORAL - EQ 10MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;ORAL - EQ 20MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;ORAL - EQ 40MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;ORAL - EQ 5MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons